Discontinued — last reported Q2 '23
Medline, Inc. Acquisitions increased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from -$6.00M to $0.00.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
acquisitions| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.00M | $4.00M | $4.00M | $4.00M | $281.50M | $281.50M | $281.50M | $281.50M | -$6.00M | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | >999% | +0.0% | +0.0% | +0.0% | -102.1% | +100.0% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | >999% | -102.1% | +100.0% |